Corey N. Fishman's Net Worth

$175 Thousand

Estimate Recalculated Feb 7, 2024 03:59PM EST

Who is Corey N. Fishman?

Corey N. Fishman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Iterum Therapeutics plc, Durata Therapeutics, Inc., MOMENTA PHARMACEUTICALS INC, and BIOSPECIFICS TECHNOLOGIES CORP.

SEC CIK

Corey N. Fishman's CIK is 0001553594

Past Insider Trading and Trends

2018 was Corey N. Fishman's most active year for acquiring shares with 9 total transactions. Corey N. Fishman's most active month to acquire stocks was the month of May. 2014 was Corey N. Fishman's most active year for disposing of shares, totalling 6 transactions. Corey N. Fishman's most active month to dispose stocks was the month of October. 2013 saw Corey N. Fishman paying a total of $374,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2020 Corey N. Fishman cashed out on 8,018 shares for a total of $197,220.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Iterum Therapeutics plc (ITRM) Snapshot price: $1.73

Chief Executive Officer

Corey N. Fishman owns 54,449 units of Ordinary Shares which is worth $94,196.77. From 2018 to 2023 Corey N. Fishman acquired a total of 450,733 shares in Iterum Therapeutics plc at a cost of $72,328.60, Corey also disposed a total of 91,128 shares of Iterum Therapeutics plc equalling to $153,275.53.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.50%
10K
$1.59
$15,863.00
54.45K
Nov 20
Form 4
—
0
—
—
0
Mar 31
Form 4
+24.16%
8.65K
$0.96
-$5,455.68
44.45K
Mar 11
Form 4
+66.77%
215K
—
—
537.01K
Mar 11
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Mar 11
Form 4
+34.20%
82.06K
$1.73
-$147,819.85
322.01K
Jan 25 - Jan 26
Form 4
—
0
—
—
0
Feb 15
Form 4
+0.84%
2K
$8.73
$17,465.60
239.95K
Aug 17
Form 4
+21.37%
41.9K
$13.00
—
237.95K
May 30
Form 4
—
0
—
—
0
May 24
Form 3
—
0
—
—
0
No matching records found

Durata Therapeutics, Inc. No price found

CFO&COO

Corey N. Fishman used to own units in Common Stock but no longer holds any shares there. From 2012 to 2014 Corey N. Fishman acquired a total of 22,441 shares in Durata Therapeutics, Inc., Corey also disposed a total of 24,941 shares of Durata Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-24.94K
—
—
0
Nov 17
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Feb 12
Form 4
∞
22.44K
—
—
22.44K
Mar 15 - Jul 24
Form 3
—
0
—
—
0
No matching records found

MOMENTA PHARMACEUTICALS INC No price found

Investor

Corey N. Fishman owns 10,090 units of Common Stock. From 2016 to 2019 Corey N. Fishman acquired a total of 10,090 shares in MOMENTA PHARMACEUTICALS INC.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+75.97%
4.36K
—
—
10.09K
Jun 19 - Jun 20
Form 4
∞
5.73K
—
—
5.73K
Jun 20
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Sep 22
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

BIOSPECIFICS TECHNOLOGIES CORP No price found

Investor

Corey N. Fishman used to own units in Common Stock, $0.001 par value but no longer holds any shares there. In the year 2020 Corey N. Fishman filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.02K
—
—
0
Dec 2
Form 4
—
0
—
—
0
May 1
Form 4
∞
2.02K
—
—
2.02K
Apr 13
Form 3
—
0
—
—
0
No matching records found